Polymegathism as a biomarker of mitochondrial disorders
Letter to the Editor
First Online:
Received:
Accepted:
- 14 Downloads
Notes
Authors’ contribution
JF: design, literature search, discussion, and first draft. SZ-M: literature search, discussion, and critical comments.
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflicts of interest.
References
- 1.Bakhoum MF, Wu WP, White EC et al. (2018) Mitochondrial A3243G mutation results in corneal endothelial polymegathism. Graefes Arch Clin Exp Ophthalmol doi: https://doi.org/10.1007/s00417-018-3914-z
- 2.Finsterer J, Zarrouk-Mahjoub S (2017) Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders. Neuropsychiatr Dis Treat 13:2569–2579CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Anbar M, Ammar H, Mahmoud RA. (2016) Corneal endothelial morphology in children with type 1 diabetes. J Diabetes Res 2016:7319047. doi: https://doi.org/10.1155/2016/7319047
- 4.Rummelt V, Folberg R, Ionasescu V et al (1993) Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation. Ophthalmology 100:1757–1766CrossRefPubMedGoogle Scholar
- 5.Poulton J, Finsterer J, Yu-Wai-Man P (2017) Genetic counselling for maternally inherited mitochondrial disorders. Mol Diagn Ther 21:419–429CrossRefPubMedGoogle Scholar
- 6.Finsterer J, Bindu PS (2015) Therapeutic strategies for mitochondrial disorders. Pediatr Neurol 52:302–313CrossRefPubMedGoogle Scholar
Copyright information
© Springer-Verlag GmbH Germany, part of Springer Nature 2018